Loomis, Sayles & Company’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-319
Closed -$24K 684
2019
Q1
$24K Buy
319
+122
+62% +$9.68K ﹤0.01% 623
2018
Q4
$15K Sell
197
-117
-37% -$9.16K ﹤0.01% 745
2018
Q3
$24K Buy
314
+197
+168% +$14.5K ﹤0.01% 722
2018
Q2
$8K Sell
117
-131
-53% -$8.57K ﹤0.01% 828
2018
Q1
$15K Buy
248
+131
+112% +$8.03K ﹤0.01% 789
2017
Q4
$7K Buy
117
+22
+23% +$1.4K ﹤0.01% 816
2017
Q3
$6K Hold
95
﹤0.01% 832
2017
Q2
$7K Buy
95
+39
+70% +$2.79K ﹤0.01% 834
2017
Q1
$4K Hold
56
﹤0.01% 886
2016
Q4
$4K Buy
+56
New +$3.88K ﹤0.01% 927

Other funds holding NHC

Loomis, Sayles & Company's NHC Position: Q2 2019 in Review

Loomis, Sayles & Company sold out of National Healthcare (NHC) in Q2 2019, closing a stake of 319 shares — an estimated $24K sold.

Loomis, Sayles & Company first reported a position in NHC in Q4 2016 and held it in 10 quarters. The position peaked at $24K in Q1 2019. 132 funds tracked by Wall St. Rank hold NHC as of Q2 2019.

  • Loomis, Sayles & Company reported no remaining National Healthcare position as of Q2 2019 after selling out during the quarter.
  • Loomis, Sayles & Company sold 319 National Healthcare shares in Q2 2019, an estimated $24K.
  • Loomis, Sayles & Company first reported a position in National Healthcare in Q4 2016 and held it in 10 quarters.
  • Loomis, Sayles & Company's National Healthcare position peaked at $24K in Q1 2019.
  • 132 funds tracked by Wall St. Rank held National Healthcare as of Q2 2019.

Based on Loomis, Sayles & Company's 13F filing for Q2 2019, filed 14 Aug 2019.